Provided by Tiger Trade Technology Pte. Ltd.

180 Life Sciences Corp

7.04
0.0000
Volume:- -
Turnover:78.90M
Market Cap:1.08B
PE:-0.45
High:7.04
Open:7.04
Low:7.04
Close:7.04
52wk High:17.75
52wk Low:0.6578
Shares:154.03M
Float Shares:151.00M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.4906
EPS(LYR):-15.4906
ROE:-371.02%
ROA:-55.46%
PB:201.54
PE(LYR):-0.45

Loading ...

Company Profile

Company Name:
180 Life Sciences Corp
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.